PF-07242813
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07242813, covering 2024-06-03 to 2024-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]